Theranostics: The new frontier in cancer treatment promises breakthroughs, fueling investment and interest in personalized medicine. BCC Research Study Projects a 24.0% CAGR, with Market Growth from $4.3 Billion in 2024 to $12.7 Billion by 2029. BOSTON, Sept. 26, 2024 /PRNewswire/ –…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.